A detailed history of Kensington Investment Counsel, LLC transactions in Repligen Corp stock. As of the latest transaction made, Kensington Investment Counsel, LLC holds 10,041 shares of RGEN stock, worth $1.45 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
10,041
Previous 9,857 1.87%
Holding current value
$1.45 Million
Previous $1.24 Million 20.29%
% of portfolio
0.63%
Previous 0.55%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$119.79 - $167.35 $22,041 - $30,792
184 Added 1.87%
10,041 $1.49 Million
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $4,080 - $6,220
34 Added 0.35%
9,857 $1.24 Million
Q1 2024

May 13, 2024

BUY
$170.78 - $208.42 $361,199 - $440,808
2,115 Added 27.44%
9,823 $1.81 Million
Q4 2023

Feb 15, 2024

SELL
$114.17 - $185.35 $2,511 - $4,077
-22 Reduced 0.28%
7,708 $1.39 Million
Q3 2023

Nov 09, 2023

BUY
$138.78 - $176.51 $43,299 - $55,071
312 Added 4.21%
7,730 $1.23 Million
Q2 2023

Aug 14, 2023

SELL
$138.42 - $180.31 $16,887 - $21,997
-122 Reduced 1.62%
7,418 $1.05 Million
Q1 2023

May 11, 2023

SELL
$154.26 - $198.1 $273,502 - $351,231
-1,773 Reduced 19.04%
7,540 $1.27 Million
Q3 2022

Nov 14, 2022

BUY
$160.42 - $256.21 $6,256 - $9,992
39 Added 0.42%
9,313 $1.74 Million
Q2 2022

Jul 15, 2022

BUY
$140.68 - $188.02 $619,273 - $827,664
4,402 Added 90.35%
9,274 $1.51 Million
Q1 2022

May 16, 2022

BUY
$161.19 - $257.96 $785,317 - $1.26 Million
4,872 New
4,872 $916,000
Q1 2022

May 13, 2022

SELL
$161.19 - $257.96 $1.39 Million - $2.22 Million
-8,613 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$247.59 - $304.47 $243,876 - $299,902
985 Added 12.91%
8,613 $2.28 Million
Q2 2021

Aug 13, 2021

BUY
$165.87 - $220.95 $29,358 - $39,108
177 Added 2.38%
7,628 $1.52 Million
Q1 2021

May 13, 2021

BUY
$180.37 - $226.26 $83,511 - $104,758
463 Added 6.63%
7,451 $1.45 Million
Q4 2020

Feb 16, 2021

BUY
$148.08 - $206.57 $1.03 Million - $1.44 Million
6,988 New
6,988 $1.34 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Kensington Investment Counsel, LLC Portfolio

Follow Kensington Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kensington Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kensington Investment Counsel, LLC with notifications on news.